Mukta Arts (MUKART) : Multiplex Screen Expansion To Drive Revenue..
Mukta Arts (MUKART) : Multiplex Screen Expansion To Drive Revenue..
October 7, 2016
Rating matrix
Rating
Target
Target Period
Potential Upside
:
:
:
:
Unrated
NA
NA
NA
Key financials
FY13
277.1
11.1
(1.4)
(0.6)
| Crore
Net Sales
EBITDA
Net Profit
EPS (|)
FY14
308.3
3.0
(7.3)
(3.3)
FY15
131.4
36.1
(8.5)
(3.8)
FY16
88.4
13.3
(3.1)
(1.4)
FY14
NA
106.5
4.6
(4.9)
(13.9)
FY15
NA
8.9
5.6
(2.8)
(19.8)
FY16
NA
24.0
6.1
3.1
(7.8)
Valuation summary
FY13
NA
28.7
4.1
3.2
(2.3)
(x)
P/E
EV / EBITDA
P/BV
RoCE (%)
RoNW (%)
Stock data
Particular
Market Capitalization (| Crore)
Total Debt (FY16) (| Crore)
Cash (FY16) (| Crore)
EV (| Crore)
52 week H/L
Equity capital (| crore)
Face value
Amount
243.9
83.4
3.9
323.4
124/ 31
11.3
5.0
Price Chart
8,500
140
120
8,000
100
7,500
80
7,000
60
40
6,500
20
6,000
0
Dec-15
Mar-16
Price (R.H.S)
| 108
Jun-16
Nifty (L.H.S)
Research Analysts
Bhupendra Tiwary
bhupendra.tiwary@icicisecurities.com
Sneha Agarwal
sneha.agarwal@icicisecurities.com
FY12
219.7
12.9
16.5
7.3
15
3.9
24.7
(6.3)
26.2
FY13
277.1
11.1
-1.4
(0.6)
NA
4.1
28.7
3.2
-2.3
FY14
308.3
3.0
-7.3
(3.3)
NA
4.6
106.5
(4.9)
-13.9
FY15
131.4
36.1
-8.5
(3.8)
NA
5.6
8.9
(2.8)
-19.8
FY16
88.4
13.3
-3.1
(1.4)
NA
6.1
24.0
3.1
-7.8
Key Financials
Exhibit 2: Revenue, EBITDA, PAT trends
350.0
250.0
308.3
277.1
300.0
219.7
200.0
131.4
150.0
88.4
100.0
50.0
0.0
-50.0
FY12
FY13
FY14
Net Sales
FY15
EBITDA
FY16
PAT
30.0
30.0
27.4
25.0
15.0
15.0
10.0
5.9
FY12
FY13
(10.0)
4.0
1.0
(5.0)
10.0
(%)
(%)
20.0
5.0
FY14
26.2
20.0
3.2
-2.3
FY12 (6.3) FY13
(20.0)
FY15
FY16
(2.8)
FY14
FY15
-13.9
-19.8
3.1
FY16-7.8
(30.0)
EBITDA (%)
Source: Capitaline, ICICIdirect.com Research
(4.9)
RoCE (%)
RoE (%)
Distribution and
exhibition
6%
Page 2
RATING RATIONALE
Pankaj Pandey
Head Research
pankaj.pandey@icicisecurities.com
Page 3
ANALYST CERTIFICATION
We /I, Bhupendra Tiwary MBA, Sneha Agarwal, MBA Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately
reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this
report.
Page 4